Endometrial Mixed Cell Adenocarcinoma

general

An adenocarcinoma that arises from the endometrium and is characterized by the presence of both type I and type II endometrial adenocarcinoma components. The minor component constitutes at least 5% of the entire tumor.

77

Centers

246

Active Trials

Cancer Funding

Specific Cancer Types(1)

Top Centers for Endometrial Mixed Cell Adenocarcinoma(77)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
69.1
2
NCI Comprehensive
Active Research Program
69.1
369.1
4
NCI Comprehensive
Active Research Program
69.1
5
NCI Comprehensive
Active Research Program
69.1
6
NCI Comprehensive
Active Research Program
69.1
7
NCI Clinical
Active Research Program
69.1
8
Active Research Program
69.1
9
NCI Comprehensive
Active Research Program
69.1
10
NCI Clinical
Active Research Program
69.1
11
Active Research Program
69.1
12
NCI Comprehensive
Active Research Program
69.1
13
Active Research Program
69.1
14
Active Research Program
69.1
15
NCI Comprehensive
Active Research Program
58.2
16
NCI Comprehensive
Active Research Program
58.2
17
NCI Comprehensive
Active Research Program
58.2
18
NCI Comprehensive
Active Research Program
58.2
19
NCI Comprehensive
Active Research Program
58.2
20
NCI Comprehensive
Active Research Program
58.2
21
NCI Comprehensive
Active Research Program
58.2
22
NCI Comprehensive
Active Research Program
58.2
23
NCI Comprehensive
Active Research Program
58.2
24
NCI Comprehensive
Active Research Program
58.2
25
NCI Comprehensive
Active Research Program
58.2
26
NCI Comprehensive
Active Research Program
58.2
27
NCI Comprehensive
Active Research Program
58.2
28
NCI Comprehensive
Active Research Program
58.2
29
NCI Comprehensive
Active Research Program
58.2
30
NCI Clinical
Active Research Program
58.2
31
Active Research Program
58.2
3258.2
33
Active Research Program
58.2
34
Active Research Program
58.2
35
Active Research Program
58.2
36
Active Research Program
58.2
37
Active Research Program
58.2
38
NCI Comprehensive
Active Research Program
45.7
39
NCI Comprehensive
Active Research Program
45.7
40
NCI Comprehensive
Active Research Program
45.7
41
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
45.7
42
NCI Comprehensive
Active Research Program
45.7
43
NCI Comprehensive
Active Research Program
45.7
44
NCI Comprehensive
Active Research Program
45.7
45
Active Research Program
45.7
46
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
45.7
47
Active Research Program
45.7
48
NCI Clinical
Active Research Program
45.7
49
NCI Comprehensive
Active Research Program
45.7
50
NCI Comprehensive
Active Research Program
45.7
51
NCI Comprehensive
Active Research Program
45.7
52
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
45.7
53
NCI Comprehensive
Active Research Program
45.7
54
Active Research Program
45.7
55
Active Research Program
45.7
56
Active Research Program
45.7
5745.7
58
NCI Comprehensive
Contributing Research Center
34.3
59
NCI Comprehensive
Contributing Research Center
34.3
60
NCI Comprehensive
Contributing Research Center
34.3
61
NCI Comprehensive
Contributing Research Center
34.3
62
NCI Comprehensive
Contributing Research Center
34.3
63
NCI Comprehensive
Contributing Research Center
34.3
64
NCI Comprehensive
Contributing Research Center
34.3
65
NCI Comprehensive
Contributing Research Center
34.3
66
NCI Clinical
Contributing Research Center
34.3
67
NCI Comprehensive
Contributing Research Center
34.3
68
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Contributing Research Center
34.3
69
Contributing Research Center
34.3
70
NCI Basic_laboratory
Contributing Research Center
34.3
71
Contributing Research Center
34.3
72
Contributing Research Center
34.3
73
Contributing Research Center
34.3
74
Contributing Research Center
34.3
75
Contributing Research Center
34.3
76
Contributing Research Center
34.3
7728.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →